Riyadh: The Saudi Food and Drug Authority (SFDA) CEO Dr. Hisham Aljadhey yesterday launched the "Traveler's Permit for Controlled Drugs" service at LEAP25. This initiative aims to enhance the travel experience for individuals requiring controlled medications while ensuring appropriate oversight.
According to Saudi Press Agency, the service enables travelers arriving in or departing from Saudi Arabia to declare their possession of controlled medications in advance. By submitting the required documentation, including details on the type and quantity of medication and the duration of stay, through the Electronic Controlled Drugs System (CDS) at https://cds.sfda.gov.sa/, travelers can obtain the necessary permits. Applications will be reviewed and processed according to established procedures. Upon approval, travelers can present the permit to relevant authorities at ports of entry and during their stay in the Kingdom.
This service strengthens the oversight and monitoring of controlled drugs, working in conjunction with relevant government authorities. It ensures adherence to local and international travel regulations and prevents misuse, restricting the transport of these drugs to authorized individuals or their designated representatives.
Furthermore, the traveler's permit service simplifies the declaration process, creating a more transparent and efficient tourist experience. This contributes to a smoother entry, stay, and departure, ultimately enhancing Saudi Arabia's appeal as a leading global tourist destination, in line with Saudi Vision 2030.